BOI.PA - Boiron SA

Boiron SA

2, avenue de l'Ouest Lyonnais
Messimy 69510
France
33 4 78 45 61 00
http://www.boiron.com

Sector: Healthcare
Industry: Drug Manufacturers - Major
Full-time employees: 3,084

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Valérie Lorentz-Poinsot	Gen. Mang. & Exec. Director	1.26M	N/A	1969
Mr. Bruno Grange	International Controller & Director	132.66k	N/A	1953
Mr. Jean-Christophe Bayssat	Deputy GM, Chief Pharmacist & Director of Pharmaceutical Devel.	1.07M	N/A	1963
Mr. Christian Boiron	Director	932.8k	N/A	1948
Fabrice Rey	Group Treasurer	N/A	N/A	N/A

Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Boiron SA, through its subsidiaries, engages in the manufacture and sale of homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines; and proprietary, branded homeopathic medicines. Its branded homeopathic medicines are used for the treatment of influenza symptoms; coughs; benign trauma in the absence of open wounds; bruising, contusions, and muscle fatigue; teething problems for nursing babies; anxiety and emotional disorders, and minor sleep disorders; cold symptoms and rhinitis; ocular discomfort and irritation due to various causes for adults and children; and vocal disorders. The company offers its products through distribution centers, pharmacy chains, wholesalers, supermarkets, drugstores, and health food stores. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Corporate governance

Boiron SA’s ISS governance QualityScore as of 1 April 2019 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.